IMOS Board of Directors

President

Joseph Kash
Joseph J. Kash, MD
Edward Hospital
Edward Cancer Center
Dr. Kash is a physician with Edward Cancer Center who enjoys   treating patients across the entire continuum of cancer care, from prevention through end of life care and survivorship. He specializes in the treatment of breast cancer, Non-Hodgkin's Lymphoma and Hodgkin's Disease, and the management of hypercoagulable states: pulmonary embolism and DVT.

President-Elect

Gary MacVicar
Gary MacVicar, MD
Illinois CancerCare, PC

Before joining Illinois CancerCare in 2013, Dr. MacVicar was an assistant professor at Northwestern University and participated in the clinical investigation of genitourinary malignancies. An active researcher, he has been involved with several clinical trials cooperative groups, include ECOG and the Prostate Cancer Clinical Trials Consortium, and has served on the NCCN Prostate Cancer Guidelines Panel and the NCI Prostate Cancer Task Force.

Secretary/Treasurer

Donna Krueger, RN, OCN
Illinois Cancer Specialists

Immediate Past President

Pankaj Kumar
Pankaj Kumar, MD
Illinois CancerCare, PC
Prior to joining Illinois CancerCare, Dr. Kumar was a medical oncologist and hematologist at Centre Medical and Surgical Associates in State College, Pennsylvania, and  an assistant professor of medicine at Penn State College of Medicine. 

Fellows Liaison

Abeer Arain, MD, MPH
University of Illinois Urbana Champaign

Members-at-Large

Madhuri Bajaj
Madhuri Bajaj, MD
Illinois CancerCare, PCP
Prior to joining Illinois CancerCare in 2012, Dr. Bajaj worked as an Academic Hospitalist at Wayne State University in Detroit, MI. She believes the development of targeted molecular therapies is the first successful step towards personalized medicine and is excited for the future of cancer care.
Sunandana Chandra
Sunandana Chandra, MD
Northwestern University
Dr. Chandra is a medical oncologist and hematologist and is part of the Developmental Therapeutics Program. She has special interest in the development of clinical trials and the study of novel biomarkers that may be used as prognostic and predictive tools in the management of melanoma and other skin cancers.
Diane Gerards-Benage, CMPE
Quincy Medical Group
Janelle L. Hamilton, CPC, CPC-P
Illinois CancerCare, PC
Karthik Koduru
Karthik Koduru, MD
Quincy Medical Group
Dr. Koduru is a medical oncologist who enjoys the multidisciplinary approach high-quality cancer care requires. He is a member of the Quincy Medical Group Clinical Research team and has an interest in a variety of cancers, including those of the brain, lungs, and prostate, as well as a clinical interest in leukemia and several types of lymphomas.
Blase N. Polite
Blase N. Polite, MD, MPP
University of Chicago
Dr. Polite is an Associate Professor of Medicine at the University of Chicago and Chief Quality Officer for the Section of Hematology/Oncology. He is Past-Chair of the ASCO Health Disparities Committee and ASCO Government Relations Committee, having served on the alternative payment models and value-based care taskforce. He currently serves on the Alliance GI and disparities committee, and is the primary colorectal oncologist at the University of Chicago. He is actively involved at the Federal and local level in developing alternative payment models for cancer care.  

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949
Email Us